חזרה לתוצאות החיפוש

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Haematological Malignancy · Acute Myeloid Leukemia · Non Hodgkin Lymphoma · Multiple Myeloma · Higher-risk Myelodysplastic Syndrome · Peripheral T Cell Lymphoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Emory Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Dr Nisha Joseph, MD) · winship.referrals@emoryhealthcare.org · 404-778-1900
    Contact: Principal Investigator (Dr Nisha Joseph, MD)

  • Community Health Network, Indianapolis, Indiana, United States

    Contact: Study coordinator (Pablo M Bedano, MD) · pbedano@ecommunity.com · 317-621-4300
    Contact: Principal Investigator (Pablo M Bedano, MD)

  • The Center for Cancer and Blood Disorders (CCBD), Bethesda, Maryland, United States

    Contact: Study coordinator (Nejma Louahlia) · Nejma.louahlia@aoncology.com · 301-571-2016
    Contact: Principal Investigator (Victor Priego, MD)

  • Nebraska Cancer Specialists, Omaha, Nebraska, United States

    Contact: Study coordinator (Ashley Servais) · aservais@nebraskacancer.com · 402-955-2691
    Contact: Principal Investigator (Stefano Tarantolo, MD)

  • University of Nebraska Medical Center, Omaha, Nebraska, United States

    Contact: Study coordinator (Marnee Strege, RN BSN) · marnee.strege@unmc.edu · 402-559-8155
    Contact: Principal Investigator (Sarah Holstein, MD)

  • Penn Medicine - Abramson Cancer Center Perelman, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Dan Vogl, MD) · dan.vogl@pennmedicine.upenn.edu · 215-662-7140
    Contact: Principal Investigator (Dan Vogl, MD)

  • Institute Bergonie, Bordeaux, France

  • Gustave Roussy, Villejuif, France

  • Hospital Germans Trias i Pujol/ ICO Badalona, Badalona, Spain

    Contact: Study coordinator (Albert Oriol-Rocafiguera)

  • University Hospital Vall D'Hebron, Barcelona, Spain

  • Hospital Clínic de Barcelona, Barcelona, Spain

    Contact: Study coordinator (Laura Rosiñol Dachs)

  • ICO L'Hospitalet (Instituto Catalán de Oncología), Barcelona, Spain

    Contact: Study coordinator (Anna Sureda Balari)

  • Hospital Universitario de La Princesa, Madrid, Spain

    Contact: Study coordinator (Adrian Alegre Amor)

  • Hospital Universitario Gregorio Marañón, Madrid, Spain

    Contact: Study coordinator (Cristina Encinas Rodriguez)

  • Hospital Infanta Leonor, Madrid, Spain

    Contact: Study coordinator (Jose Angel Hernandez- Rivas)

  • Hospital Universitario Ramón y Cajal, Madrid, Spain

    Contact: Study coordinator (María J Blanchard Rodriguez)

  • Hospital Universitario 12 de Octubre, Madrid, Spain

    Contact: Study coordinator (Joaquin Martinez-Lopez)

  • CIOCC Hospital Universitario HM Sanchinarro, Madrid, Spain

  • Universidad de Navarra, Pamplona, Spain

    Contact: Study coordinator (Paula Rodriguez-Otero)

  • Hospital Universitario y Politécnico La Fe de la Comunidad Valenciana, Valencia, Spain

    Contact: Study coordinator (Javier de la Rubia Comos)

  • Karolinska Comprehensive Cancer Center, Stockholm, Sweden

  • The Royal Marsden, Sutton, Surrey, United Kingdom

    Contact: Study coordinator (Charlotte Pawlyn)

  • The Clatterbridge Cancer Centre NHS Foundation Trust,, Bebington, United Kingdom

    Contact: Study coordinator (Gillian Brearton, MD) · gillian.brearton@nhs.net · +44 (0) 151 318 8583
    Contact: Principal Investigator (Gillian Brearton, MD)

  • University Hospitals Bristol, Bristol, United Kingdom

    Contact: Study coordinator (Sally Moore, MD) · sally.moore@uhbw.nhs.uk · 44 117 923 0000

  • University Hospital of Wales, Cardiff, United Kingdom

    Contact: Study coordinator (Steven Knapper)

  • Royal Derby Hospital, Derby, United Kingdom

    Contact: Study coordinator (Firas Al-Kaisi, MD) · firas.abed@nhs.net · +44 (0) 133 278 7971
    Contact: Principal Investigator (Firas Al-Kaisi, MD)

  • Western General Hospital, Edinburgh, United Kingdom

    Contact: Study coordinator (Victoria Campbell)

  • Gartnavel General Hospital, Glasgow, United Kingdom

    Contact: Study coordinator (Jennifer Travers)

  • Leicester Royal Infirmary, Leicester, United Kingdom

    Contact: Study coordinator (Harriet Walter)

  • St Bartholomew's Hospital, London, United Kingdom

    Contact: Study coordinator (Heather Oakervee)

  • Sarah Cannon Research Institute UK, London, United Kingdom

    Contact: Study coordinator (Richard Dillon)

  • NIHR University College London Clinical Research Facility, London, United Kingdom

    Contact: Study coordinator (Jenny O'Nions)

  • Imperial College, London, United Kingdom

    Contact: Study coordinator (Aristeidis Chaidos) · aristeidis.chaidos@nhs.net · 44 20 3313 8117

  • The Christie Hospital, Manchester, United Kingdom

    Contact: Study coordinator (Tim Somervaille)

  • Newcastle upon Tyne Hospitals, Newcastle upon Tyne, United Kingdom

    Contact: Study coordinator (Thomas Creasey) · thomas.creasey1@nhs.net

  • Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

    Contact: Study coordinator (Dean Smith)

  • Cancer and Haematology Centre, Oxford, United Kingdom

    Contact: Study coordinator (Sarah Gooding)

  • University Hospital of Southampton, Southampton, United Kingdom

    Contact: Study coordinator (Andy Davies)

  • Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom

    Contact: Study coordinator (Kamaraj Karunanithi)
מובילי המחקר

  • Tim Somervaille

    Principal Investigator

    The Christie NHS Foundation Trust

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)